Biotech
GENEVA, SWITZERLAND: Four Abstracts to Be Presented on NI-0501 for Treatment of Hemophagocytic Lymphohistiocytosis (HLH); Poster on NI-0101 for Rheumatoid Arthritis ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 11/02/15 -- Vivione Biosciences Inc. ("Vivione" or the "Corporation") (TSX VENTURE: VBI) is pleased to announce the completion of the first t ...
NEW YORK, NY: Phase 1b/2a Study Being Expanded; Planned Registration Study to Follow ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/02/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today reported financial results for the third quarter 2015. Revenue for the third quarter ended ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 11/02/15 -- ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") is pleased to announce the appointment of Mr ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 10/30/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), a leading immuno-oncology company, announces that it has raised A$2.0 million via an equity placement at ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/30/15 -- Theravance, Inc. (NASDAQ: THRX) today announced that it is commencing its previously announced "modified Dutch auction" tender offer ...
REDWOOD CITY, CA: REDWOOD CITY, CA -- (Marketwired) -- 10/30/15 -- ARMO BioSciences, Inc., a leading developer of immuno-oncology therapeutics, today announced that positive results from an ongoing Phase 1 clinical tr ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 10/29/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on Novemb ...
ANN ARBOR, MI: ANN ARBOR, MI -- (Marketwired) -- 10/29/15 -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced that ...
LAVAL, QUEBEC: - Clinical Trial Application clearance received from MHRA in the UK - Enrollment of patients to commence in Q4 2015 ...
SOUTH SAN FRANCISCO, CA: US BREO(R) ELLIPTA(R) Sales Up by More Than 40% in U.S. Market Quarter Over Quarter; Initiates a $150 Million Stock Repurchase Program to Accelerate the Company's Capital Return Plan; Announces I ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 10/27/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced receipt of notice ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 10/27/15 -- (NASDAQ: CBLI) today announced that on November 5, 2015, it will report its financial results for the third quarter and nine-month period ended September ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/27/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that it will present preclinical data on tarloxotinib bromide*, or "tarloxo ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 10/27/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)Belgium's Federal Agency for Medicines and Health Products Approved the Commencement of the AIPAC Stud ...
